The European Rare Diseases Research Alliance (ERDERA)is pleased to pre‑announce the upcoming launch of the ERDERA Clinical Trial Call 2026, expected to open on 1 July 2026. You can read the pre-announcement document here and the draft Call text here.
The ECTC aims to support multinational, Good Clinical Practice (GCP)‑compliant Phase I, Phase I/II and Phase II interventional clinical trialsin rare diseases. The purpose is to generate robust clinical evidence and, where appropriate, data of regulatory relevance to support future interactions with regulatory authorities and subsequent clinical development.
The call is designed to address specific challenges of clinical trials in rare diseases, where patient populations are often small and geographically dispersed, making multinational collaboration essential.
An information webinar for prospective applicants will take place on 6 July 2026 (15:00–17:00 CEST) and will provide an overview of the call objectives, eligibility requirements, evaluation process and indicative timeline. More information and registration here.